Alberto Sanchez-Fueyo
King's College London · Hospital Clinic of Barcelona · Hospital Clinic Barcelona / IDIBAPS, Barcelona, Spain
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alberto Sanchez-Fueyo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:48 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06371924 · Immunometabolism of Machine Perfusion StrategiesKing's College Hospital NHS Trust · recruiting · Liver Transplantation · principal investigator
- Ph4NCT02949492 · Low-dose IL-2 for Treg Expansion and Tolerance (LITE)King's College London · terminated · Transplantation, Liver Diseases · principal investigator
- Ph4NCT02498977 · Liver Immunosuppression Free TrialKing's College London · terminated · Transplantation, Liver · principal investigator
- N/ANCT01445236 · Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of ToleranceHospital Clinic of Barcelona · terminated · Liver Transplantation · principal investigator
- Ph2NCT01034345 · Effect of Rapamycin on Tolerance-related Biomarkers on Stable Liver Transplant RecipientsHospital Clinic of Barcelona · unknown · Liver Transplantation
- Ph2NCT00668369 · Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver TransplantationHospital Clinic of Barcelona · completed · Hepatitis C Virus Infection, Liver Transplantation · principal investigator
- Ph2NCT00647283 · Assessment Of the Safety and Benefit of Prospective Immunosuppressive Drug Withdrawal in Liver Transplantation and Prediction of Operational ToleranceHospital Clinic of Barcelona · unknown · Liver Transplantation · principal investigator
- Ph2NCT00436722 · Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative TrialHospital Clinic of Barcelona · terminated · Liver Diseases · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:48 UTC. The ranking covers the 200 most relevant of 11 PubMed records, and a shared surname and initials can bring in a namesake. All 11 on PubMed
- Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients.Hepatology · 2013258 citationsRCR 7.8
- Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation.Am J Transplant · 2020192 citationsRCR 8.7
- Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation.J Clin Invest · 2012167 citationsRCR 5.0
- Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans.Sci Transl Med · 202284 citationsRCR 5.7
- HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans.Sci Transl Med · 201474 citationsRCR 2.2
- Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans.J Hepatol · 202368 citationsRCR 6.2
- ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation.Am J Transplant · 201058 citationsRCR 1.8
- Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial.Am J Transplant · 202139 citationsRCR 2.8
- Hypothermic oxygenated machine perfusion influences the immunogenicity of donor livers in humans.Liver Transpl · 202513 citationsRCR 4.7
- Donor-specific immune senescence as a candidate biomarker of operational tolerance following liver transplantation in adults: Results of a prospective, multicenter cohort study.Am J Transplant · 202510 citationsRCR 2.7